Saturday, July 11, 2026

Drug profile · INN

iodine povacrylex

iodine povacrylex (DURAPREP) is a skin preparation/antiseptic, oxidising agent. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iodine povacrylex
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

iodine povacrylex (DURAPREP) is a skin preparation/antiseptic, oxidising agent. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN iodine povacrylex
Brand DURAPREP
Mechanism Skin preparation/antiseptic, oxidising agent
Route TOPICAL
Formulation SPONGE

Mechanism of action

Skin preparation/antiseptic, oxidising agent

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iodine povacrylex?

iodine povacrylex (DURAPREP) is a skin preparation/antiseptic, oxidising agent. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for iodine povacrylex?

DURAPREP is a marketed brand name for iodine povacrylex. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iodine povacrylex?

iodine povacrylex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.